Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B

This study has been completed.
Sponsor:
Collaborator:
Schering-Plough
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00275938
First received: January 11, 2006
Last updated: NA
Last verified: January 2006
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: June 2001
  Estimated Primary Completion Date: No date given